- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- August 2023
- 175 Pages
Global
From €3056EUR$3,185USD£2,643GBP
€4366EUR$4,550USD£3,775GBP
From €124EUR$129USD£107GBP
- Report
- May 2023
- 147 Pages
Global
From €5756EUR$5,999USD£4,977GBP
- Book
- June 2018
- 368 Pages
- Book
- August 2014
- 240 Pages
The Pluripotent Cell market is a subset of the larger Stem Cell market. Pluripotent cells are stem cells that have the potential to differentiate into any type of cell in the body. They are used in research and development of treatments for a variety of diseases, including cancer, diabetes, and neurological disorders. Pluripotent cells are also used in regenerative medicine, where they are used to replace damaged or diseased cells.
The Pluripotent Cell market is highly competitive, with a number of companies offering products and services. These companies include Thermo Fisher Scientific, Merck KGaA, Lonza Group, STEMCELL Technologies, and Cellular Dynamics International. These companies provide a range of products and services, including cell culture media, cell lines, and cell-based assays. They also offer services such as cell banking, cell line development, and cell-based drug discovery. Show Less Read more